READING THE INVISIBLE- The Science and Clinical Interpretation of Thoracic Infrared Thermology
Advancing Men’s Breast Health: Thermal Imaging, Vascular Assessment, and the Potential Role of Functional Imaging in Male Breast Cancer Evaluation
An anonymized comparative educational analysis of actual reports interpreted by Dr. Phil Hoekstra, DABT
Introduction: Understanding What the Human Eye Cannot See
Medical infrared thermology examines patterns of heat emitted from the body’s surface. Unlike mammography, ultrasound, or MRI, which principally depict anatomical features, thermography records skin-surface thermal distribution that can reflect superficial blood flow, autonomic regulation, and other physiological influences. The distinction is important: a thermal image does not directly show a tumor or identify malignant cells.
Men’s breast health deserves greater clinical and public attention. Although male breast cancer is uncommon, men may overlook breast or nipple changes or delay seeking evaluation. Two anonymized thoracic examinations interpreted by Dr. Phil Hoekstra illustrate how the laboratory measures and classifies thermal patterns across the male chest. One report describes a persistent asymmetric pattern assigned TH-4 on one side; the other describes bilateral TH-1 findings. These reports offer useful examples of physiological documentation, not evidence that thermography is an effective standalone screening test for male breast cancer.

click to enlarge
How the Technology Identifies and Reads Thermal Patterns: Infrared cameras detect radiation emitted by the skin and
convert it into apparent surface-temperature measurements. Calibrated color
palettes make thermal contrasts visible: warmer and cooler colors correspond to
temperature ranges on each image’s scale, not to particular diseases. Both reports
include anterior and lateral views, temperature reference points, and replicate
imaging sets. The interpreter considers regional symmetry, focal thermal
differences, the configuration and extent of superficial vascular patterns, and
the distribution of thermal emissions.

A valuable distinction is between what the instrument measures and what the clinician infers. The camera measures surface infrared emission; descriptions such as hyperthermia, asymmetry, and vascular pattern characterize the resulting image. Assertions about possible underlying malignancy are interpretations that require independent clinical confirmation.
The reports describe the challenge as intended to distinguish normally regulated vessels from potentially unregulated hyperemia. Nevertheless, thermal responses can be affected by inflammation, autonomic variation, medication, ambient conditions, and acquisition technique. A response pattern is not a cancer-specific test.
The right side received TH-4 and the left TH-1 across all three study dates. The interpreter described relatively small interval changes in vascular extent, caliber, and thermal emission and considered the persistence of the pattern relevant to the assessment. The report associated the TH-4 pattern with an approximate 65% risk of malignant disease. This is the laboratory’s stated estimate, not a confirmed diagnosis or an independently verified probability for this individual. The report recommended further objective evaluation and a comparative restudy in 90–120 days.
Report B: Symmetrical Thermal Findings: The second report found essentially symmetrical thermal patterns across both pectoral regions, without significant focal or complex vascular asymmetries or disproportionate whole-region hyperthermia. Following the cold challenge, both sides demonstrated symmetric adaptive attenuation. The laboratory assigned TH-1 to both regions and recommended annual comparative thermology.
A critical qualification appears in this report: the images did not conform to standardized protocols. That limitation matters when interpreting the strength and reproducibility of the findings. TH-1 means no qualifying thermological signs were identified under the laboratory’s criteria; it does not rule out cancer or other breast pathology.
Inside the Reports: What the Observations Add
Selected brief excerpts show the difference between measurable findings and their clinical interpretation:Vascular
configuration — Report A, p. 2
“An asymmetric, moderately hyperthermic, diffuse and vascular pattern”
Value: documents the location and character of a surface thermal asymmetry.
Limitation: cannot establish its underlying cause.
Dynamic response —
Report A, p. 2
“symmetric and adaptive attenuation of the emission levels”
Value: describes physiological change following a defined stimulus, adding a
second dimension to static imaging.
Longitudinal
comparison — Report A, p. 2
“increases of extent, caliber and relative emission levels”
Value: records changes in image characteristics over time, although evolution
is not specific to malignancy.
Normal classification
— Report B, p. 1
“does not indicate any thermology Signs or Criteria”
Value: illustrates how an examination without qualifying abnormalities is
categorized under this laboratory’s framework.
The TH Scoring System: What the Numbers Mean- The reports reference the Marseille thermological classification system, developed in the 1970s, which grades findings from TH-1 to TH-5 using defined thermal signs and criteria. These two examples substantiate the following narrower interpretation: TH-1 denotes no qualifying concerning signs, whereas TH-4 denotes multiple signs that the laboratory considers associated with increased malignancy risk. The reports do not supply a full criterion-by-criterion definition of TH-2, TH-3, or TH-5; those categories should not be reconstructed from these examples. TH scores are not interchangeable with BI-RADS categories.
|
Characteristic |
Report A |
Report B |
|
Right pectoral TH score |
TH-4 |
TH-1 |
|
Left pectoral TH score |
TH-1 |
TH-1 |
|
Thermal distribution |
Asymmetric right-sided pattern |
Essentially symmetrical |
|
Post-challenge response |
Adaptive attenuation |
Symmetric adaptive attenuation |
|
Temporal comparison |
Three examinations |
No prior comparison listed |
|
Laboratory conclusion |
Concerning thermological signs |
No qualifying thermological signs |
Thermography is not an FDA-approved replacement for mammography, and evidence does not establish it as an effective standalone breast cancer screening method in men. Any palpable lump, nipple discharge, nipple inversion, skin change, or other suspicious symptom warrants clinical examination and appropriate established diagnostic imaging, commonly diagnostic mammography and/or targeted ultrasound as indicated.
Conclusion: A Responsible Role in Men’s Breast Health
Dr. Hoekstra’s contrasting reports help explain how a laboratory transforms thermal measurements into descriptive findings and TH classifications. The TH-4 case shows how persistent regional asymmetry and vascular characteristics can prompt concern and further evaluation; the bilateral TH-1 case illustrates the absence of qualifying signs within the same interpretive framework. Neither classification independently diagnoses or excludes cancer.
For men’s breast health, the principal present value of these examples is educational: they encourage attention to male chest and breast changes and show how functional observations differ from structural diagnosis. Whether standardized infrared thermology can contribute clinically useful supplementary information to male breast cancer pathways remains a research question. Awareness, timely evaluation of symptoms, and evidence-based diagnostic care must remain central.
Source and Editorial Notes
Primary sources: two
anonymized reports titled “Analysis of Thoracic Thermology,” interpreted by Dr.
Phil Hoekstra, DABT (2023, five pages; 2026, three pages). All patient names,
dates of birth, scan identifiers, and referring clinician information have been
omitted. Selected short excerpts are reproduced for critical educational
commentary; original thermograms and proprietary page layouts are not
reproduced.
Medical disclaimer:
This paper summarizes laboratory interpretations; it does not independently
validate risk percentages, test performance claims, or clinical outcomes.
Infrared thermography should not replace established breast cancer screening or
diagnostic imaging.























